1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MESO TV: Sacituzumab targeting TROP-2 for mesothelioma

Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma.

Our Sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Belluck Law, Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; Bristol Myers Squibb; The Gori Law Firm

Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv.

Also...

In Other News

Share:

Facebook
Twitter
LinkedIn